Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jul 27, 2021 (5 years ago)

Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Rite Aid ALLERGY RELIEF Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistamine, 24 count bottle, Made in the Czech Republic, Distributed by Rite Aid 30 Hunter Lane Camp Hill PA 17011 NDC 11822-0425-0 UPC 0 11822 85410 8

Affected NDC 11822-0425-00

Compare with the code on your package — it is the most precise check available.

Drug: Fexofenadine Category: Allergy & Cold Medication

Recalling firm
Perrigo Company PLC
NDC code
11822-0425-0
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0347-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fexofenadine recalls

See all
Class II · Moderate risk

Fexofenadine Hydrochloride Tablets

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Completed Microbial contamination Sun Pharmaceutical Industries INC NDC 51660-998-30 D-0273-2024
Class II · Moderate risk

Allergy Relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation L. Perrigo Company NDC 36800-691-39 D-0912-2023
Class II · Moderate risk

Picnic

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation L. Perrigo Company D-0911-2023
Class II · Moderate risk

allergy relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation L. Perrigo Company NDC 11673-617-22 D-0910-2023

Other recalls by Perrigo Company PLC

All 2021 recalls
Class II · Moderate risk

Maximum Strength Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-989-10 D-0629-2022
Class II · Moderate risk

Maximum Strength Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-989-10 D-0628-2022
Class II · Moderate risk

Sinus Severe

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 55910-696-10 D-0627-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 49035-388-10 D-0626-2022